Winslow Evans & Crocker’s Clovis Oncology, Inc. CLVS Stock Holding History
Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2020
Q4 | $8K | Buy |
1,580
+800
| +103% | +$4.05K | ﹤0.01% | 1007 |
|
2020
Q3 | $5K | Sell |
780
-100
| -11% | -$641 | ﹤0.01% | 896 |
|
2020
Q2 | $6K | Hold |
880
| – | – | ﹤0.01% | 866 |
|
2020
Q1 | $8K | Sell |
880
-600
| -41% | -$5.46K | ﹤0.01% | 782 |
|
2019
Q4 | $18K | Buy |
1,480
+480
| +48% | +$5.84K | ﹤0.01% | 700 |
|
2019
Q3 | $4K | Hold |
1,000
| – | – | ﹤0.01% | 1044 |
|
2019
Q2 | $16K | Hold |
1,000
| – | – | ﹤0.01% | 731 |
|
2019
Q1 | $26K | Hold |
1,000
| – | – | 0.01% | 621 |
|
2018
Q4 | $18K | Sell |
1,000
-1,400
| -58% | -$25.2K | 0.01% | 650 |
|
2018
Q3 | $72K | Hold |
2,400
| – | – | 0.02% | 427 |
|
2018
Q2 | $110K | Buy |
2,400
+100
| +4% | +$4.58K | 0.03% | 356 |
|
2018
Q1 | $121K | Hold |
2,300
| – | – | 0.04% | 324 |
|
2017
Q4 | $156K | Buy |
2,300
+700
| +44% | +$47.6K | 0.05% | 297 |
|
2017
Q3 | $132K | Buy |
1,600
+600
| +60% | +$49.4K | 0.04% | 310 |
|
2017
Q2 | $93.6K | Buy |
+1,000
| New | +$93.6K | 0.03% | 444 |
|